Aubrey Rankin - Net Worth and Insider Trading
Aubrey Rankin Net Worth
The estimated net worth of Aubrey Rankin is at least $2 Million dollars as of 2024-11-13. Aubrey Rankin is the President, Innovation & Tech of Revance Therapeutics Inc and owns about 571,376 shares of Revance Therapeutics Inc (RVNC) stock worth over $2 Million. Details can be seen in Aubrey Rankin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aubrey Rankin has not made any transactions after 2021-12-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aubrey Rankin
Aubrey Rankin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aubrey Rankin owns 1 companies in total, including Revance Therapeutics Inc (RVNC) .
Click here to see the complete history of Aubrey Rankin’s form 4 insider trades.
Insider Ownership Summary of Aubrey Rankin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2022-03-15 | director |
Aubrey Rankin Latest Holdings Summary
Aubrey Rankin currently owns a total of 1 stock. Aubrey Rankin owns 571,376 shares of Revance Therapeutics Inc (RVNC) as of December 3, 2021, with a value of $2 Million.
Latest Holdings of Aubrey Rankin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2021-12-03 | 571,376 | 4.13 | 2,359,783 |
Holding Weightings of Aubrey Rankin
Aubrey Rankin Form 4 Trading Tracker
According to the SEC Form 4 filings, Aubrey Rankin has made a total of 11 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years, including 1 buys and 10 sells. The most-recent trade in Revance Therapeutics Inc is the acquisition of 30,000 shares on December 3, 2021, which cost Aubrey Rankin around $432,900.
Insider Trading History of Aubrey Rankin
- 1
Aubrey Rankin Trading Performance
GuruFocus tracks the stock performance after each of Aubrey Rankin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aubrey Rankin is 3.77%. GuruFocus also compares Aubrey Rankin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aubrey Rankin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aubrey Rankin's insider trading performs compared to the benchmark.
Performance of Aubrey Rankin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.92 | | | | | |
| Relative Return to S&P 500(%) | 11.23 | | | | | |
Aubrey Rankin Ownership Network
Ownership Network List of Aubrey Rankin
Ownership Network Relation of Aubrey Rankin
Aubrey Rankin Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
Aubrey Rankin is the director of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, Aubrey Rankin made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 124,284 shares made by Mark J Foley , a net sale of 35,664 shares made by Tobin Schilke , and a net sale of 64,379 shares made by Dwight Moxie .
In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,445 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 264,445 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
Aubrey Rankin Mailing Address
Above is the net worth, insider trading, and ownership report for Aubrey Rankin. You might contact Aubrey Rankin via mailing address: C/o Revance Therapeutics, Inc, 7555 Gateway Blvd, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
